How to Measure Innovation as a Capability

Measuring a single innovation asks whether one idea is working, and measuring a portfolio asks whether the mix of bets adds up. Measuring innovation as a capability asks the broadest question of the three, and for an established company the most valuable: can this organization reliably turn ideas into outcomes, again and again? That's not a single number. It's a read across four things: whether innovation has a real strategic mandate, whether it's governed to fit, whether the process runs on evidence, and whether the decision discipline holds when it counts.

The reason to do this at all is that the alternative is expensive. As we argued in the elephant in the room, the avoidance of meaningful innovation metrics is a primary driver of innovation-program failure. A capability that can't show its value can't defend its budget, and it gets cut the moment conditions tighten. It also hides the most common failure pattern in mature companies: ten projects in flight and nothing reaching launch, a pipeline that looks busy while producing nothing. You can only see that pattern if you're measuring the capability, not just the projects.

Here is the structure worth measuring against.

Strategic alignment and mandate

The first question is whether innovation is actually written into the company's strategy, with accountability for defined outcomes, or whether it's an orphaned activity that survives on a sponsor's goodwill. A capability with a real mandate has a portfolio objective it can be held to: the specific growth, entry, or defensive outcomes the portfolio exists to produce, stated in terms leadership can be accountable for. Measure whether that objective exists, whether it's tied to corporate strategy, and how high the accountability for it reaches. A mandate that lives only with the innovation team is the low-maturity signal, and it predicts that the rest of the capability won't hold up either.

Governance

The second question is whether the operating model is designed to fit innovation, or borrowed wholesale from the core business. Innovation governed by default corporate rules tends to be funded on the calendar and judged by uniform criteria, which is exactly wrong for work whose defining feature is uncertainty. A capability built to fit funds against evidence-readiness rather than the budget cycle, differentiates its criteria by the class of innovation, and defines clear decision and exit rights. Measure whether governance was deliberately designed for the work, or whether every exception has to be fought for one project at a time.

Process

The third question is whether the pipeline and portfolio disciplines are actually run. Two things are worth separating here, because conflating them is one of the most common diagnostic errors in mature companies. A pipeline is process, how a single opportunity moves through stages. A portfolio is intentional risk distribution with strategic intent, which opportunities run, in what mix, against the objective. As we've written in the uncomfortable truth about your innovation portfolio strategy, many companies run something that looks like a pipeline but has no portfolio governance underneath it. Measure whether ideas advance through real, evidence-based stage decisions, and whether the portfolio is an intentional, differentiated mix aimed at the objective rather than simply whatever happened to get funded.

Discipline

The fourth question is whether the discipline holds when it's inconvenient. A stage-gate only matters if the organization uses it honestly, in both directions. That means decisions follow the evidence even when it disappoints, weak bets are actually stopped and their resources redeployed, and success isn't defined so narrowly that a well-judged stop looks like a failure. Every gate review resolves to one of four outcomes, Continue, Pivot, Pause, or Stop, and a capability with discipline is willing to call the last of those when the evidence warrants it, as we detail in when to stop.

Discipline also depends on the criteria behind the decisions. Strong criteria are customized and prioritized for the organization, and they grow in number and rigor as the stakes climb; by the time real money is committed there are dozens of them, matched to the level of investment and the class of the bet. Measure whether the organization's decisions run on comprehensive, appropriately calibrated criteria, or on conviction and sunk cost.

Turning the read into a number

These four dimensions are diagnostic, not decorative. Assessed honestly, they tell you where a capability is strong, where it's weak, and what to fix first, which is the whole point of measuring a capability rather than admiring a pipeline. BRI's Innovation Capability Assessment is built to produce exactly this read: it scores an organization across the disciplines of innovation practice and the organizational conditions that determine whether that practice survives, and it names the highest-leverage gaps to address first.

Measuring the capability is what moves innovation from an act of faith to something an organization can govern, fund, and improve on purpose. It's the difference between hoping the next idea works and knowing whether you've built a machine that reliably turns ideas into outcomes. Building and measuring that machine is what our consulting work and Growth Forge® Software are built to make repeatable.

BRI Associates helps companies grow by drawing on decades of practitioner experience in corporate innovation and new business development — practitioners, not pundits or academics — through direct consulting, training workshops, and Growth Forge® Software, built for the unique requirements of corporate innovation and growth organizations.